HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of axitinib rechallenge in metastatic renal cell carcinoma.

AuthorsKotaro Suzuki, Takuto Hara, Tomoaki Terakawa, Kenichi Harada, Masato Fujisawa
JournalInternational journal of urology : official journal of the Japanese Urological Association (Int J Urol) Vol. 28 Issue 6 Pg. 702-703 (06 2021) ISSN: 1442-2042 [Electronic] Australia
PMID33719092 (Publication Type: Journal Article)
Chemical References
  • Antineoplastic Agents
  • Indazoles
  • Protein Kinase Inhibitors
  • Axitinib
Topics
  • Antineoplastic Agents (therapeutic use)
  • Axitinib (adverse effects)
  • Carcinoma, Renal Cell (drug therapy)
  • Humans
  • Indazoles (adverse effects)
  • Kidney Neoplasms (drug therapy)
  • Protein Kinase Inhibitors (adverse effects)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: